India, July 20 -- Fangzhou Inc. (6086.HK) has signed a Memorandum of Understanding with Novo Nordisk (NOVOB.CO,NVO) to collaborate on the management of serious chronic diseases, including diabetes and obesity.
Fangzhou has collaborated with Novo Nordisk, using their knowledge and products for treating diabetes and obesity. Fangzhou will use its smart healthcare systems and strong tech platform to build a complete service that helps people manage their health. This service will offer things like advice on using medicine, reminders to take it, tracking how well it works, and health education. Their goal is to improve the whole process of blood sugar and weight control. Instead of just treating illness, they want to focus more on keeping peop...